| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.4M | -5.6% |
| Cost of Revenue | $16.7M | -2.7% |
| R&D Expense | $9.7M | -21.5% |
| SG&A Expense | $10.8M | +5.5% |
| Operating Income | -$5.7M | -28.7% |
| Pre-tax Income | -$5.2M | -12.9% |
| Income Tax | $79K | -79.2% |
| Net Income | -$5.2M | -5.8% |
| EPS (Basic) | -$0.12 | -9.1% |
| EPS (Diluted) | -$0.12 | -9.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.9M | -22.1% |
| Accounts Receivable | $6.7M | -5.7% |
| Current Assets | $19.0M | -14.5% |
| Total Assets | $39.7M | -8.1% |
| Current Liabilities | $8.1M | -13.0% |
| Total Liabilities | $9.6M | -9.2% |
| Stockholders' Equity | $30.1M | -7.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | -27.5% |
| Capital Expenditures | $36K | -91.6% |
| Investing Cash Flow | -$1.3M | -207.7% |
| Financing Cash Flow | -$97K | +68.4% |
| Free Cash Flow | -$1.4M | +5.8% |